Purchases and Sales Made in Q3 2023 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q3 2023. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Apis Capital Advisors, LLC
New York, NY |
SELL
|
- |
-61K- 67.78% |
$684K - $906K
|
29K
$197K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-79.3K- 33.34% |
$889K - $1.18M
|
158K
$1.08M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-328K- 41.51% |
$3.68M - $4.87M
|
462K
$3.14M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-418K- 12.47% |
$4.69M - $6.22M
|
2.94M
$20M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-473K- 22.31% |
$5.3M - $7.02M
|
1.65M
$11.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-746K- 31.19% |
$8.37M - $11.1M
|
1.65M
$11.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-765K- 99.13% |
$8.59M - $11.4M
|
6.75K
$45.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.41M- 57.56% |
$15.8M - $20.9M
|
1.04M
$7.05M
|